Report: Security Lapses in Handling of Deadly Pathogens

A government report finds that laboratories in the U.S. that work with select agents such as Ebola and anthrax aren’t as secure as they should be.

Written byKatarina Zimmer
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ISTOCK, JARUN011A year-long government investigation has found that the program responsible for overseeing the laboratories that handle some of the world’s deadliest pathogens is prone to safety lapses, raising concerns about effective oversight.

Research on select agents—hazardous pathogens and toxins including Ebola and smallpox viruses and the bacteria that cause anthrax and the plague—requires federal oversight and adherence to strict regulations. However, in a report released today (October 31), the Government Accountability Office (GAO) uncovered a number of flaws in biosafety measures taken by approved laboratories and a lack of independent oversight. Ultimately, the GAO came to the conclusion that the Federal Select Agent Program, which oversees 276 “high-containment” laboratories in the U.S. that undertake research on select agents, “does not meet our key elements of effective oversight.”

There have been several severe safety lapses in recent years. In 2014, for example, a scientist at the National Institute of Health discovered a number of decades-old vials of smallpox ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • katya katarina zimmer

    After a year teaching an algorithm to differentiate between the echolocation calls of different bat species, Katarina decided she was simply too greedy to focus on one field of science and wanted to write about all of them. Following an internship with The Scientist in 2017, she’s been happily freelancing for a number of publications, covering everything from climate change to oncology. Katarina is a news correspondent for The Scientist and contributes occasional features to the magazine. Find her on Twitter @katarinazimmer and read her work on her website.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas